Published in Am J Gastroenterol on December 01, 2003
Serotonin signalling in the gut--functions, dysfunctions and therapeutic targets. Nat Rev Gastroenterol Hepatol (2013) 1.57
Candidate genes and sensory functions in health and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2008) 1.19
Pharmacology of serotonin: what a clinician should know. Gut (2004) 1.02
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol (2009) 1.00
Physiological underpinnings of irritable bowel syndrome: neurohormonal mechanisms. J Physiol (2014) 0.96
The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome. Dig Dis Sci (2009) 0.95
Enteropathogenic Escherichia coli infection inhibits intestinal serotonin transporter function and expression. Gastroenterology (2009) 0.93
Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) (2014) 0.91
Effect of the 5-HT4 receptor and serotonin transporter on visceral hypersensitivity in rats. Braz J Med Biol Res (2012) 0.89
LX-1031, a tryptophan 5-hydroxylase inhibitor, and its potential in chronic diarrhea associated with increased serotonin. Neurogastroenterol Motil (2010) 0.89
IBS--review and what's new. MedGenMed (2006) 0.87
Serotonin in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes (2009) 0.87
Imbalanced shift of cytokine expression between T helper 1 and T helper 2 (Th1/Th2) in intestinal mucosa of patients with post-infectious irritable bowel syndrome. BMC Gastroenterol (2012) 0.84
Is there a SERT-ain association with IBS? Gut (2004) 0.84
Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender. J Gastroenterol (2009) 0.83
Neuroendocrine markers and psychological features in patients with irritable bowel syndrome. Int J Colorectal Dis (2013) 0.82
Rotavirus and Serotonin Cross-Talk in Diarrhoea. PLoS One (2016) 0.79
Differential diagnosis between functional and organic intestinal disorders: is there a role for non-invasive tests? World J Gastroenterol (2007) 0.78
Changes in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome. Biopsychosoc Med (2008) 0.78
Intestinal secretory mechanisms in irritable bowel syndrome-diarrhea. Clin Gastroenterol Hepatol (2014) 0.78
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Pathophysiology, Evaluation, and Management of Chronic Watery Diarrhea. Gastroenterology (2016) 0.75
Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenic E. coli (EPEC). Am J Physiol Gastrointest Liver Physiol (2017) 0.75
QUANTUM ESPRESSO: a modular and open-source software project for quantum simulations of materials. J Phys Condens Matter (2009) 14.22
Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology (2008) 5.77
Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. Hepatology (2013) 3.06
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation. Hypertension (2013) 2.82
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision. World J Biol Psychiatry (2008) 2.64
Molecular basis of resistance to azole antifungals. Trends Mol Med (2002) 2.48
Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine. Cancer Res (2006) 2.38
Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol (2003) 2.34
Thyroid disorders in chronic hepatitis C. Am J Med (2004) 2.19
An inter- and intra-laboratory comparison of breath ¹³CO₂analysis. Aliment Pharmacol Ther (2003) 2.03
Lack of pharmacokinetic bioequivalence between generic and branded amoxicillin formulations. A post-marketing clinical study on healthy volunteers. Br J Clin Pharmacol (2009) 1.81
Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol (2007) 1.78
Immunity, inflammation and cancer: a leading role for adenosine. Nat Rev Cancer (2013) 1.69
TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severity. J Virol (2003) 1.58
Risk factors for Barrett's esophagus: a case-control study. Int J Cancer (2002) 1.49
Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey. EuroIntervention (2015) 1.47
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients. Clin Cancer Res (2008) 1.46
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection. Expert Rev Clin Pharmacol (2014) 1.45
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: an Italian study of incident cases. Dig Liver Dis (2012) 1.45
Treatment non-response in OCD: methodological issues and operational definitions. Int J Neuropsychopharmacol (2002) 1.39
Cholinergic toxic syndrome by the anticancer drug irinotecan: acetylcholinesterase does not play a major role. Clin Pharmacol Ther (2002) 1.39
Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord (2007) 1.38
Cellular and pharmacogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small-cell lung cancer cells. Mol Pharmacol (2005) 1.31
Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) (2002) 1.30
Periorbital necrotising fasciitis. Br J Ophthalmol (2009) 1.28
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol (2002) 1.27
Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy. Oncologist (2010) 1.26
Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. J Med Chem (2011) 1.26
Biosimilar drugs : concerns and opportunities. BioDrugs (2007) 1.26
Epidemiologic and clinical updates on impulse control disorders: a critical review. Eur Arch Psychiatry Clin Neurosci (2006) 1.25
Proteome analysis of whole saliva: a new tool for rheumatic diseases--the example of Sjögren's syndrome. Proteomics (2007) 1.23
Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem (2003) 1.23
Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer. Mol Cancer Ther (2006) 1.20
Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther (2008) 1.19
Pharmacological issues of linezolid: an updated critical review. Clin Pharmacokinet (2010) 1.16
Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol (2011) 1.16
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther (2009) 1.15
Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers. J Proteome Res (2008) 1.14
Vascular endothelial growth factor levels in immunodepleted plasma of cancer patients as a possible pharmacodynamic marker for bevacizumab activity. J Clin Oncol (2007) 1.12
Efficacy of Nissen fundoplication versus medical therapy in the regression of low-grade dysplasia in patients with Barrett esophagus: a prospective study. Ann Surg (2006) 1.12
Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev (2010) 1.11
How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related? World J Gastroenterol (2012) 1.11
Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines. Clin Cancer Res (2004) 1.11
Proteomic analysis of saliva: a unique tool to distinguish primary Sjögren's syndrome from secondary Sjögren's syndrome and other sicca syndromes. Arthritis Res Ther (2011) 1.08
Pharmacogenetics of anticancer drug sensitivity in non-small cell lung cancer. Pharmacol Rev (2003) 1.08
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer. Clin Cancer Res (2009) 1.06
Electronic structure of surface-supported bis(phthalocyaninato) terbium(III) single molecular magnets. Nano Lett (2008) 1.06
Radionuclide gastroesophageal motor studies. J Nucl Med (2004) 1.06
Brain-derived neurotrophic factor plasma levels in patients suffering from post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry (2009) 1.05
Impact of Clinical Presentation on Dual Antiplatelet Therapy Duration: Let's Re-Evaluate Our Priorities. J Am Coll Cardiol (2015) 1.05
Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol (2013) 1.05
Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med (2012) 1.04
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study. Hepatology (2015) 1.03
Refractory obsessive-compulsive disorder: state-of-the-art treatment. J Clin Psychiatry (2002) 1.03
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension (2006) 1.02
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther (2007) 1.01
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Curr Drug Targets (2012) 1.01
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer. Cancer Chemother Pharmacol (2009) 1.01
Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol (2006) 1.01
Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily. Pharmacol Res (2002) 1.01
Simple and reliable method for detection and genotyping of hepatitis C virus RNA in dried blood spots stored at room temperature. J Clin Microbiol (2002) 1.01
Vertebroplasty and kyphoplasty: complementary techniques for the treatment of painful osteoporotic vertebral compression fractures. A prospective non-randomised study on 154 patients. Eur Spine J (2009) 1.01
Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol (2003) 1.01
A rapid high-performance liquid chromatography method to measure linezolid and daptomycin concentrations in human plasma. Ther Drug Monit (2010) 1.01
Accuracy of b-GGT fraction for the diagnosis of non-alcoholic fatty liver disease. Liver Int (2011) 1.00
Pharmacokinetic-pharmacodynamic relationships of the anthracycline anticancer drugs. Clin Pharmacokinet (2002) 0.99
Dielectric and thermal effects on the optical properties of natural dyes: a case study on solvated cyanin. J Am Chem Soc (2011) 0.99
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy. Pharmacol Res (2008) 0.99
Serotonin receptors of type 6 (5-HT6): from neuroscience to clinical pharmacology. Curr Med Chem (2013) 0.99
Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy. Pharmacogenomics (2007) 0.98
Angiogenesis and invasion in gliomas. Cancer Treat Res (2004) 0.98
Comparative distribution of azithromycin in lung tissue of patients given oral daily doses of 500 and 1000 mg. J Antimicrob Chemother (2003) 0.98
Kleptomania: clinical features and comorbidity in an Italian sample. Compr Psychiatry (2002) 0.98